Drug Profile
Research programme: 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors - Connexios
Alternative Names: CNX-010; CNX-010-49Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Connexios Life Sciences
- Class Small molecules
- Mechanism of Action 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus(In the elderly) in India
- 09 May 2014 Preclinical development is ongoing in India
- 09 May 2014 This programme is available for partnering or licensing as of 09 May 2014. http://connexios.com/